Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LPCN
MRKR
Add up to 3 more stocks
LPCN
Lipocine Inc.
+0.97%
$2.09+0.02Delayed quote: Oct 6, 2026, 12:48 PM EDT
Market Cap
$17.23M
52W Range
$1.81 - $12.37
MRKR
Marker Therapeutics, Inc.
-3.77%
$1.02-0.04Delayed quote: Oct 6, 2026, 12:44 PM EDT
Market Cap
$17.01M
52W Range
$0.84 - $2.46
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.79 | 1.40 |
| P/S Ratio | 10.98 | 13.79 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -334.3% | 0.0% |
| Operating Margin | -524.7% | 0.0% |
| Net Margin | -755.1% | -706.2% |
| ROE | -54.5% | -71.6% |
| ROA | -49.7% | -59.7% |
| ROIC | -57.7% | -88.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 11.48 | 6.03 |
| Quick Ratio | 11.48 | 6.03 |
| Debt/Equity | 0.00 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.